Advertisement

Intensive Care Medicine

, Volume 22, Issue 5, pp 404–408 | Cite as

Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock

  • G. Marecaux
  • M. R. Pinsky
  • E. Dupont
  • R. J. Kahn
  • J. -L. Vincent
Original

Abstract

Objective

Both serum levels of tumor necrosis factr-α (TNFα) and interleukin-6 (IL-6) and blood lactate levels in patients with septic shock have been shown to correlate with prognosis. The aim of the study was to define the relative predictive value of these measures.

Patients

38 hospitalized patients with septic shock, including 18 survivors and 20 non-survivors.Intervention: Blood TNFα (immunoradiometric assay), IL-6 (bioassay) and lactate (enzymatic method) levels were serally measured at the onset of septic shock and after 24 and 48 h.

Results

TNFα levels tended to be higher in the non-surviors than in the survivors at the onset of shock (204±392 vs 129±195 pg/ml,p-NS) but decreased similary in both goups with time (p=0.03). IL-6 levels at admission, were highly variable (9656±19851 U/ml in the non-surviours and 69222±248804 U/ml in the survivors). Log IL-6 decreased similarly in both groups with time (p=0.004). Admission blood lactate levels were higher in the nonsurviours than in the survivors (6.11±4.78 mEq/l vs 3.49±2.00 mEq/l,p<0.05) and decreased significantly with time in all patients (p=0.024.), However, this decrease was greater in the survivors than in the non-surviors (p=0.003).

Conclusion

These data indicate that the large variability in TNFα and IL-6 level limit their prognostic significance in patients with septic shock. The predictive value of the trend in cytokine levels over time is not superior to that of trends in blood lactate levels.

Key words

Blood lactate Cytokine levels Septic shock 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rackow EC, Astiz ME, Bone RC (1991) Pathophysiology and treatment of septic shock. JAMA 266:548–554Google Scholar
  2. 2.
    Vincent JL (1991) Diagnostic and medical management/supportve care of patients with gram-negative bacteria and septic shock. Infect Dis Clin North Am 5:807–816Google Scholar
  3. 3.
    Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457–469Google Scholar
  4. 4.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 202:685–693Google Scholar
  5. 5.
    Tran DD, Groeneveld ABJ, Vander Meulen J Nauta JJP, Strack Van Schijindel RJM, Thijs LG (1990) Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 18: 474–479Google Scholar
  6. 6.
    Vincent JL, Berlot G (1992) Cardiac effects of the meditors of sepsis. In: Lamy M, Thijs L (eds) Update on intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 255–266Google Scholar
  7. 7.
    Beutler B, Milsark IW, Cerami A (1985) Passive immunization against cachectin/TNF protects mice from lethal effect of endotoxin. Science 229:869–871Google Scholar
  8. 8.
    Michie HR, Manogue KR, Springgs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerani A, Wolff SM, Wilmore DW (1989) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486Google Scholar
  9. 9.
    Van Deuren M, Van der Ven-Jongekrijk J Demacker PN, Bartelink AK, Van Dalen R, Sauerwein RW, Gallati M, Vannice JL, Van der Meer JW, (1994) Differential expression of proiflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169:157–161Google Scholar
  10. 10.
    Keuter M, Dahrmana E, Gasem MH, Van der Ven-Jongekrijk J, Demaker P, Sauerwein R, Gallati M, Van der Meer JW (1994) Patterns of proinflamatory cytokines and inhibitors during typhoi fever. J Infect Des 169: 1306–1311Google Scholar
  11. 11.
    Preiser JC, Schmartz D, Van der Linden P, Content J, Vandenbussche P, Burruman W, Sebald W, Dupont E, Pinsky MR, Vincent JL (1991) IL-6 administration has no acute hemodynamic effect in the dog. Cytokine 3:1–4Google Scholar
  12. 12.
    Waage A, Aasen AO (1992) Different role of cytokine mediators in spectic shock related to meningococcal disease and surgery. Immunology 127:221–230Google Scholar
  13. 13.
    Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JM, Strack Van Schijndel RJM, Erenberg-Belner AJM, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704–1710Google Scholar
  14. 14.
    Calandra T, Baumgartner JD, Grau DG, Wu MM, Lambert PM, Schellekens J, Verhoef J, Gauser MP (1990) Prochnostic values of tumor necrosis factor/caheric, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161:982–987.Google Scholar
  15. 15.
    Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23–29Google Scholar
  16. 16.
    Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975–979Google Scholar
  17. 17.
    Marks JD, Marks CB, Luce JM, Montgomery AB, Turner CB, Metz CA, Murray JF (1990) Plasma tumor neucosis factor in patients with septic shock. Am Rev Respir Dis 141:94–97Google Scholar
  18. 18.
    De Groote M, Martin MA, Densen P, Pfaller MA, Wenzel RP (1989) Plasma tumor necrosis levels in patients with presumed sepsis. JAMA 262:249–251Google Scholar
  19. 19.
    Debets JM, Kampmeijer R, Van der Linden MP, Buurman WA, Van der Linden CJ (1989) Plasma tumor necrosis factors and mortality in critically ill septic patients. Crit Care Med 17: 489–494Google Scholar
  20. 20.
    Pinsky MR, Vincent JL, Deviere J, Alegre M, Schandene L, Kahn RJ, Vandenbussche P, Content J, Dupont E (1993) Serum cytokine levels in human septic shock: relation to multiple-systems organ failure and mortality. Chest 103:565–575Google Scholar
  21. 21.
    Offner F, Philippe J, Vogelaers DP, Colardyn FC, Baele G, Baudrihaye M, Vermeulen A, Leroux-Roels G (1990) Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116:100–105Google Scholar
  22. 22.
    Casay LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome [see comments]. Ann Intern Med 119:771–778Google Scholar
  23. 23.
    Vitek V, Cowley RA (1971) Blood lactate in the prognostic of various forms of shock. Ann Surg 173:308–313Google Scholar
  24. 24.
    Bakker J, Vincent JL (1991) The oxygen supply dependency phenomenon is associated with increased blood lactate levels. J Crit Care 6:152–159Google Scholar
  25. 25.
    Bakker J, Coffernis M, Leon M, Gris P, Vincent JL (1991) Blood lactate leveis are superior to oxygen derived variables in predicting outcome in human septic shock. Chest 99:956–962Google Scholar
  26. 26.
    Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ (1983) Serial lactate determinations during circulatory shock. Crit Care Med 11:449–451Google Scholar
  27. 27.
    Mizock BA, Falk JL (1992) Lactic acidosis in critical illness. Crit Care Med 20:80–93Google Scholar
  28. 28.
    Waage A, Brandtzae GP, Halstensen A, Kierulf P, Espevik T (1989) The complex patern of cytokines in serum from patients with menigococcal septic shock. J Exp Med 189:333–338Google Scholar
  29. 29.
    Damas P, Ledoux D, Nys M, Vridts Y, DeGroote D, Franchimont P, Lamy M (1992) Cytokine serum levels during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356–362Google Scholar
  30. 30.
    Ohzato H, Yoschizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kihimoto T, Mori T (1992) Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 111: 201–209Google Scholar
  31. 31.
    Hall G, Desborough JP (1992) Interleukin-6 and the metabolic response to surgery. Br J Anaesth 69:337–338Google Scholar
  32. 32.
    Fassbender K, Pargger H, Muller W, Zimmerli W (1993) Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients; diagnostic signs in nosocomial infection. Crit Care Med 21:1175–1180Google Scholar
  33. 33.
    Hoch R, Rodriguez R, Manning T, Bishop MJ, Mead P, Shoemaker WC, Abraham E (1993) Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21:839–845Google Scholar
  34. 34.
    Rodriguez J, Miller C, Garner W, Till G, Gerrero P, Moore N, Corridore M, Normolle D, Smith D, Remick D (1993) Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 34: 684–695Google Scholar
  35. 35.
    Parsons P, Moore A, Moore EE, Ikle D, Henson P, Worthen G (1992) Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 146:694–700Google Scholar
  36. 36.
    Van Deventer SJ, Hart M, Van der Poll T, Hack E, Aarden LA (1993) Endotoxin and tumor necrosis factor alpha induced interleukin-8 release in humans, J Infect Dis 167:461–464Google Scholar
  37. 37.
    Van Zee KJ, DeForge L, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Moldawer LL (1991) IL-8 in septic shock, endotoxinemia and after IL-1 administration. J Immunol 146: 3478–3482Google Scholar
  38. 38.
    Waring P, Wycherley K, Cary D, Nicola N, metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031–2037Google Scholar
  39. 39.
    Marchant A, Devière J, Byl B, De Groote D, Vincent JL (1994) Interleukin-10 production during septicaemia. Lancet 344:707–708Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • G. Marecaux
    • 1
  • M. R. Pinsky
    • 3
  • E. Dupont
    • 2
  • R. J. Kahn
    • 1
  • J. -L. Vincent
    • 1
  1. 1.Department of Intensive Care, Erasme HospitalFree University of BrusselsBrusselsBelgium
  2. 2.Department of Immunology, Erasme HospitalFree University of BrusselsBrusselsBelgium
  3. 3.Department of Anesthesiology and Critical Care MedicineUniversity of PittsburghUSA

Personalised recommendations